Aliases & Classifications for Spinal Cord Disease

Summaries for Spinal Cord Disease

MedlinePlus : 41 your spinal cord is a bundle of nerves that runs down the middle of your back. it carries signals back and forth between your body and your brain. it is protected by your vertebrae, which are the bone disks that make up your spine. if you have an accident that damages the vertebrae or other parts of the spine, this can also injure the spinal cord. other spinal cord problems include tumors infections such as meningitis and polio inflammatory diseases autoimmune diseases degenerative diseases such as amyotrophic lateral sclerosis and spinal muscular atrophy symptoms vary but might include pain, numbness, loss of sensation and muscle weakness. these symptoms can occur around the spinal cord, and also in other areas such as your arms and legs. treatments often include medicines and surgery.

MalaCards based summary : Spinal Cord Disease, also known as spinal cord diseases, is related to vascular myelopathy and htlv-1 associated myelopathy/tropical spastic paraparesis, and has symptoms including back pain, headache and hemiplegia. An important gene associated with Spinal Cord Disease is AQP4 (Aquaporin 4), and among its related pathways/superpathways is Spinal Cord Injury. The drugs Propofol and Sevoflurane have been mentioned in the context of this disorder. Affiliated tissues include spinal cord, bone and brain, and related phenotype is renal/urinary system.

Wikipedia : 72 Myelopathy describes any neurologic deficit related to the spinal cord. When due to trauma, it is known... more...

Related Diseases for Spinal Cord Disease

Diseases related to Spinal Cord Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 91)
id Related Disease Score Top Affiliating Genes
1 vascular myelopathy 12.2
2 htlv-1 associated myelopathy/tropical spastic paraparesis 12.1
3 myelopathy, htlv-1-associated 12.1
4 syphilitic myelopathy 12.1
5 retrovirus-associated myelopathy 12.0
6 tropical spastic paraparesis 11.7
7 spondylosis 11.4
8 foix-alajouanine syndrome 11.1
9 human t-cell leukemia virus type 1 11.1
10 tabes dorsalis 11.0
11 neuroschistosomiasis 11.0
12 ossification of the posterior longitudinal ligament of spine 10.9
13 sneddon syndrome 10.7
14 central nervous system disease 10.7
15 tarlov cysts 10.7
16 carotid artery thrombosis 10.7 AQP4 AVPR2
17 variola major 10.7 CD40LG MBP
18 chronic duodenal ileus 10.7 CD40LG MBP
19 alopecia intellectual disability syndrome 2 10.7 MBP MOG
20 myelitis 10.7
21 paraurethral gland cancer 10.7 AQP4 SERPINH1
22 cogan-reese syndrome 10.7 AQP4 MBP
23 hypersplenism 10.6 AQP4 MBP
24 viral meningitis 10.6 CD40LG HSF4
25 diabetic peripheral angiopathy 10.6 AQP4 CD40LG MOG
26 allergic contact dermatitis of eyelid 10.6 AQP4 BTD MOG
27 psychologic vaginismus 10.6 ADAMTS1 GDNF
28 rickettsialpox 10.6 CD40LG TNF
29 gestational diabetes 10.6 CD40LG MBP
30 submandibular gland disease 10.6 CD40LG TNF
31 mixed cell adenoma 10.5 AQP4 MBP MOG
32 temporal arteritis 10.5 CD40LG MBP MOG
33 littre gland carcinoma 10.5 ADAMTS1 MBP
34 newborn respiratory distress syndrome 10.5 AQP4 MBP MOG
35 hypertensive heart disease 10.5 CD40LG HSF4
36 ileocolitis 10.5 CD40LG GDNF TNF
37 discharging ear 10.5 CD40LG ERVW-1
38 ovarian surface papilloma 10.4 MBP MOG
39 hyperostosis 10.4 AVPR2 MBP SERPINH1
40 spinal stenosis 10.4 AQP4 GDNF TNF
41 tricho onychic dysplasia 10.4 AQP4 MBP TNF
42 eye carcinoma in situ 10.4 CD40LG MOG TNF
43 ulcerative colitis 10.4 AQP4 MBP TNF
44 peripheral nervous system disease 10.4 AVPR2 CD40LG TNF
45 ovarian mucinous adenofibroma 10.4 MBP MOG TNF
46 proximal symphalangism 10.4 MBP MOG TNF
47 ceruminous carcinoma 10.4 CD40LG MBP TNF
48 upper gum cancer 10.3 GDNF TNF
49 choreatic disease 10.3 CD40LG MBP TNF
50 hepatic angiomyolipoma 10.3 AQP4 GDNF MBP MOG

Comorbidity relations with Spinal Cord Disease via Phenotypic Disease Network (PDN):


Acute Cystitis Decubitus Ulcer
Deficiency Anemia Hypertension, Essential
Osteoporosis Paraplegia
Prostate Cancer Spinal Stenosis

Graphical network of the top 20 diseases related to Spinal Cord Disease:



Diseases related to Spinal Cord Disease

Symptoms & Phenotypes for Spinal Cord Disease

UMLS symptoms related to Spinal Cord Disease:


back pain, headache, hemiplegia, myoclonus, pain, sciatica, seizures, syncope, tremor, chronic pain, hyperexplexia, vertigo/dizziness, sleeplessness

MGI Mouse Phenotypes related to Spinal Cord Disease:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 renal/urinary system MP:0005367 9.17 ADAMTS1 AQP4 AVPR2 BTD CD40LG GDNF

Drugs & Therapeutics for Spinal Cord Disease

Drugs for Spinal Cord Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 642)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Propofol Approved, Investigational, Vet_approved Phase 4 2078-54-8 4943
2
Sevoflurane Approved, Vet_approved Phase 4 28523-86-6 5206
3
Acetylcholine Approved Phase 4,Phase 2,Phase 3 51-84-3 187
4
Lidocaine Approved, Vet_approved Phase 4,Phase 2 137-58-6 3676
5
Pregabalin Approved, Illicit, Investigational Phase 4,Phase 3 148553-50-8 5486971
6
Benzocaine Approved Phase 4,Phase 1,Phase 2 1994-09-7, 94-09-7 2337
7
Riluzole Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 1744-22-5 5070
8
Mitoxantrone Approved, Investigational Phase 4 65271-80-9 4212
9
Dopamine Approved Phase 4,Phase 2,Phase 3,Phase 1 51-61-6, 62-31-7 681
10
Menthol Approved Phase 4,Phase 2,Phase 3,Phase 1 2216-51-5 16666
11
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2,Early Phase 1 83-43-2 6741
12
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2,Early Phase 1 50-24-8 5755
13
Oxybutynin Approved, Investigational Phase 4,Phase 3,Phase 2 5633-20-5 4634
14
Meloxicam Approved, Vet_approved Phase 4,Phase 3 71125-38-7 5281106 54677470
15
Norepinephrine Approved Phase 4,Phase 2 51-41-2 439260
16
Neostigmine Approved, Vet_approved Phase 4,Phase 1,Early Phase 1 59-99-4 4456
17
Darifenacin Approved, Investigational Phase 4 133099-04-4 444031
18
Trospium Approved Phase 4,Phase 1 10405-02-4, 47608-32-2 5596 5284631
19
Tadalafil Approved, Investigational Phase 4,Phase 3 171596-29-5 110635
20 Piracetam Approved Phase 4,Phase 3,Phase 2 7491-74-9
21
Amitriptyline Approved Phase 4 50-48-6 2160
22
Perphenazine Approved Phase 4 58-39-9 4748
23
Carbamazepine Approved, Investigational Phase 4 298-46-4 2554
24
Oxcarbazepine Approved Phase 4 28721-07-5 34312
25
Teriparatide Approved, Investigational Phase 4,Phase 2 52232-67-4 16133850
26
Zoledronic acid Approved Phase 4,Phase 3,Phase 2,Phase 1 118072-93-8 68740
27
Goserelin Approved Phase 4 65807-02-5 47725 5311128
28
Mexiletine Approved Phase 4,Phase 2 31828-71-4 4178
29
Interferon beta-1a Approved, Investigational Phase 4,Phase 2 145258-61-3 6438354
30
Edetic Acid Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 60-00-4, 62-33-9 6049
31
Iron Approved Phase 4,Phase 3,Phase 2,Phase 1 7439-89-6 23925
32
Bupropion Approved Phase 4 34841-39-9, 34911-55-2 444
33
Citalopram Approved Phase 4,Phase 3,Phase 1 59729-33-8 2771
34
Neomycin Approved, Vet_approved Phase 4 1404-04-2 8378
35
Phenol Approved, Experimental Phase 4 108-95-2 996
36
Zinc Approved Phase 4,Phase 3,Phase 1,Phase 2 7440-66-6 32051 23994
37 Zinc sulfate Approved Phase 4 7733-02-0
38
Ramipril Approved Phase 4 87333-19-5 5362129
39
Ethanol Approved Phase 4,Phase 3,Phase 2,Early Phase 1 64-17-5 702
40
Mycophenolate mofetil Approved, Investigational Phase 4,Phase 2 128794-94-5 5281078
41
Mycophenolic acid Approved Phase 4,Phase 2 24280-93-1 446541
42
Prednisone Approved, Vet_approved Phase 4,Phase 2 53-03-2 5865
43
Dextromethorphan Approved Phase 4,Phase 3,Phase 2 125-71-3 5360696 5362449
44
Guaifenesin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 93-14-1 3516
45
Cycloserine Approved Phase 4 68-41-7 401 6234
46
Isoflurane Approved, Vet_approved Phase 4 26675-46-7 3763
47
Trazodone Approved, Investigational Phase 4,Phase 2 19794-93-5 5533
48
Gabapentin Approved, Investigational Phase 4,Phase 3 60142-96-3 3446
49
Denosumab Approved Phase 4,Phase 2 615258-40-7
50
Exenatide Approved, Investigational Phase 4 141758-74-9 15991534

Interventional clinical trials:

(show top 50) (show all 1789)

id Name Status NCT ID Phase Drugs
1 Anesthesia Induction in Patients Undergoing Surgery for Cervical Myelopathy Unknown status NCT01052337 Phase 4 anaesthetics: sevofluorane
2 Exoskeletons for Spinal Cord Injury: A Feasibility Study Unknown status NCT01943669 Phase 4
3 Eyegaze Systems for Spinal Cord Injury: A Feasibility Study Unknown status NCT01943656 Phase 4
4 Functional Electrical Stimulation-Assisted Walking: Reduction of Secondary Complications Due to Spinal Cord Injury Unknown status NCT00201968 Phase 4
5 Botox for Neurogenic Detrusor Overactivity and the Prevention of Autonomic Dysreflexia Following SCI Unknown status NCT02298660 Phase 4 BOTOX
6 Pregabalin for the Treatment and Prevention of Spinal Cord Injury Neuropathic Pain Unknown status NCT01479556 Phase 4 Pregabalin;Placebo
7 A Study to Evaluate the Efficacy and Safety of Vardenafil in Men With Erectile Dysfunction Caused by Spinal Cord Injury Unknown status NCT00725790 Phase 4 Vardenafil;Placebo
8 Non-Invasive Ventilation in Amyotrophic Lateral Sclerosis Unknown status NCT00560287 Phase 4
9 Immunogenicity of 1 or 2 Doses of bOPV in Chilean Infants Primed With IPV Vaccine Unknown status NCT01841671 Phase 4
10 Spinal Cord Stimulation (SCS) in Refractory Angina Unknown status NCT00121654 Phase 4
11 Efficacy and Safety of Mitoxantrone in Patients With Refractory Neuromyelitis Optica and Spectrum Disorders Unknown status NCT02021825 Phase 4 Mitoxantrone
12 Clinical Study of Solifenacin Succinate in Patients With Bladder Symptoms Due to Spinal Cord Injury or Multiple Sclerosis Completed NCT00629642 Phase 4 Solifenacin Succinate;Solifenacin Succinate;Oxybutynin Hydrochloride;Placebo
13 Assessment of Surgical Techniques for Treating Cervical Spondylotic Myelopathy Completed NCT00285337 Phase 4
14 Surgical Treatment of Cervical Spondylotic Myelopathy Completed NCT00565734 Phase 4
15 Arthroplasty Versus Fusion in Anterior Cervical Surgery: Prospective Study of the Impact on the Adjacent Level Completed NCT00554528 Phase 4
16 Pregabalin and Radicular Pain Study (PARPS) Completed NCT01061697 Phase 4 Pregabalin
17 Project to Improve Symptoms and Mood in People With Spinal Cord Injury Completed NCT00592384 Phase 4 venlafaxine XR;placebo
18 Efficacy and Safety of Standard Oral Colonoscopic Preparations With or Without Neostigmine Compared to Pulse-Irrigation Colonic Lavage Completed NCT00745095 Phase 4 Neostigmine
19 Surgical Versus Nonoperative Treatment of Metastatic Epidural Spinal Cord Compression Completed NCT00634426 Phase 4
20 A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic’s Disease) Completed NCT00304291 Phase 4 Mitoxantrone
21 Comparative Study of the Efficacy and Safety of Muscarinic M3 Receptors Antagonists in the Treatment of Neurogenic Detrusor Overactivity Completed NCT00800462 Phase 4 Oxybutynin Cl;Trospium Cl;Darifenacin Hydrogen Bromide (HBr)
22 Omega-3 Supplementation for Tetraplegics With Poor Cholesterol Levels Completed NCT01896037 Phase 4
23 Effect of Tadalafil (Cialis) on the Cardiovascular System of Spinal Cord Injury (SCI) Males Completed NCT01067391 Phase 4 tadalafil;placebo
24 Functional Melatonin Replacement for Sleep Disruptions in Individuals With Tetraplegia Completed NCT00507546 Phase 4 Ramelteon;Placebo
25 Levetiracetam in Chronic Neuropathic Pain Following Spinal Cord Injury Completed NCT00252954 Phase 4 Levetiracetam
26 Chronic Pain in Spinal Cord Injury Completed NCT00006428 Phase 4 Amitriptyline
27 Assess Efficacy in Subjects With Traumatic Spinal Cord Injury Completed NCT00667966 Phase 4 Vardenafil (Levitra, BAY 38-9456), 10 mg;Placebo;Vardenafil (Levitra, BAY 38-9456), 20 mg
28 Neuropathic Pain Study With Botulinum Toxin A in Spinal Cord Injury Patients Completed NCT01579500 Phase 4 Botulinum toxin type A;normal saline
29 Investigating Botulinum Toxin A to Treat Acute Neck/Upper Shoulder Pain Following a New Spinal Cord Injury. Completed NCT00320281 Phase 4 botulinum toxin A
30 Treatment of Fecal Incontinence and Constipation in Patients With Spinal Cord Injury Completed NCT00286520 Phase 4
31 A Study Evaluating the Efficacy and Safety of Sildenafil in Men With Traumatic Spinal Cord Injury and Erectile Dysfunction Completed NCT00654082 Phase 4 sildenafil;placebo
32 Symptom Based Treatment of Neuropathic Pain Completed NCT02180880 Phase 4 Pregabalin and Oxcarbazepine
33 Pressure Ulcer Healing With Microcyn Completed NCT02001558 Phase 4 Microcyn
34 Effect of Parathyroid Hormone (PTH) and Weight-Bearing on Bone in Spinal Cord Injury (SCI) Completed NCT00826228 Phase 4 teriparatide
35 Zoledronic Acid Administration in Acute Spinal Cord Injury Completed NCT02042872 Phase 4 Zoledronic acid
36 Effect of Goserelin (Zoladex®) in Spinal and Bulbar Muscular Atrophy Completed NCT00851461 Phase 4 Goserelin
37 Myobloc Atrophy Study Completed NCT02052024 Phase 4 Botox;MYOBLOC
38 Immunogenicity of Monovalent Type 2 Oral Poliovirus Vaccine Completed NCT02643368 Phase 4
39 Intestinal and Humoral Immunity of Sequential Polio Vaccination Schedules Completed NCT02412514 Phase 4
40 Feasibility of Telesurveillance and Home Cough Assistance for Amyotrophic Lateral Patients (ALS) Completed NCT00613899 Phase 4
41 CARE Canadian ALS Riluzole Evaluation Completed NCT00542412 Phase 4 Riluzole
42 Mexiletine for the Treatment of Muscle Cramps in ALS Completed NCT01811355 Phase 4 Mexiletine;Placebo
43 Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis Completed NCT00179478 Phase 4 interferon beta 1a 30 ug IM once weekly
44 Safety and Immunogenicity of 1 or 2 Doses of IPV in Latin American Infants Primed With Bivalent OPV Vaccine Completed NCT01831050 Phase 4
45 Polio End-game Strategies - Poliovirus Type 2 Challenge Study Completed NCT02189811 Phase 4
46 Comparison of Immunogenicity and Reactogenicity of INFANRIX™ HEXA and HEXAVAC™ Vaccines as a Primary Vaccination Course Completed NCT01457547 Phase 4
47 Study to Evaluate Antibody Persistence in Children Previously Vaccinated With Infanrix Hexa™ or Infanrix-IPV/Hib™ Completed NCT01358825 Phase 4
48 Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants Completed NCT00753649 Phase 4
49 Study of a New Formulation of DTPa-HBV-IPV/Hib Vaccine Administered as a Booster Dose to 18-23 Months Old Children Completed NCT00611559 Phase 4
50 An Objective Double-blind Evaluation of Bupropion and Citalopram in an Individual With Friedreich Ataxia Completed NCT01716221 Phase 4 bupropion & Citalopram;Bupropion & Placebo;Placebo & Citalopram;Placebo & Placebo

Search NIH Clinical Center for Spinal Cord Disease

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: spinal cord diseases

Genetic Tests for Spinal Cord Disease

Genetic tests related to Spinal Cord Disease:

id Genetic test Affiliating Genes
1 Myelopathy 29

Anatomical Context for Spinal Cord Disease

MalaCards organs/tissues related to Spinal Cord Disease:

39
Spinal Cord, Bone, Brain, Testes, Bone Marrow, Skin, Heart

Publications for Spinal Cord Disease

Articles related to Spinal Cord Disease:

(show top 50) (show all 76)
id Title Authors Year
1
Primary central nervous system lymphoma of T-cell origin: an unusual cause of spinal cord disease. ( 27878765 )
2016
2
Prevalence, clinical presentation, prognosis, and outcome of 17 dogs with spinal shock and acute thoracolumbar spinal cord disease. ( 26676985 )
2016
3
The intrinsic pathogenic role of autoantibodies to aquaporin 4 mediating spinal cord disease in a rat passive-transfer model. ( 25542977 )
2015
4
Autonomic rectal dysfunction in patients with multiple sclerosis and bowel symptoms is secondary to spinal cord disease. ( 24608309 )
2014
5
Sacral neuromodulation for neurogenic bladder and bowel dysfunction with multiple symptoms secondary to spinal cord disease. ( 25224602 )
2014
6
Depression and pain among inpatients with spinal cord injury and spinal cord disease: differences in symptoms and neurological function. ( 23072715 )
2013
7
Positron emission tomography in spinal cord disease. ( 24182699 )
2013
8
STIR muscle hyperintensity in the cervical muscles associated with inflammatory spinal cord disease of unknown origin. ( 23458643 )
2013
9
Low serum vitamin D levels and recurrent inflammatory spinal cord disease. ( 22083799 )
2012
10
Stress, internal resources and functioning in a person with spinal cord disease. ( 22430577 )
2012
11
Spinal cord disease in patients with cancer. ( 22810129 )
2012
12
Anorectal function and the effect of biofeedback therapy in ambulatory spinal cord disease patients having constipation. ( 20602567 )
2010
13
Surgical management of pressure ulcers during inpatient neurologic rehabilitation: outcomes for patients with spinal cord disease. ( 19569459 )
2009
14
Clinical and magnetic resonance imaging findings in 92 cats with clinical signs of spinal cord disease. ( 18602328 )
2009
15
Characterization of spatiotemporal gait characteristics in clinically normal dogs and dogs with spinal cord disease. ( 19951114 )
2009
16
Profound biotinidase deficiency in a child with predominantly spinal cord disease. ( 18645204 )
2008
17
Rehabilitation outcomes after infection-related spinal cord disease: a retrospective analysis. ( 18356619 )
2008
18
Signs of spinal cord disease in two heifers caused by Listeria monocytogenes. ( 14758832 )
2004
19
Spinal cord disease in West Nile virus infection. ( 12571269 )
2003
20
Spinal cord disease in West Nile virus infection. ( 12575663 )
2003
21
From the electrodiagnosis lab...H-reflexes in hand muscles after cervical spinal cord disease. ( 14598812 )
2003
22
Electrophysiological evaluation of root and spinal cord disease. ( 12524565 )
2002
23
Correlation between severity of clinical signs and motor evoked potentials after transcranial magnetic stimulation in large-breed dogs with cervical spinal cord disease. ( 12420825 )
2002
24
The use of magnetic motor evoked potentials in horses with cervical spinal cord disease. ( 11902758 )
2002
25
Botulinum a toxin and detrusor sphincter dyssynergia: a double-blind lidocaine-controlled study in 13 patients with spinal cord disease. ( 12121731 )
2002
26
Intrathecal baclofen therapy for spinal origin spasticity: spinal cord injury, spinal cord disease, and multiple sclerosis. ( 22151114 )
1999
27
Spinal cord disease due to melioidosis. ( 10450444 )
1999
28
The effects of capsaicin on the neurogenic hyperreflexic detrusor. A double blind placebo controlled study in patients with spinal cord disease. Preliminary results. ( 9494998 )
1998
29
Botulinum A toxin treatment for detrusor-sphincter dyssynergia in spinal cord disease. ( 9494997 )
1998
30
Chemosensitive epidural spinal cord disease in non-Hodgkins lymphoma. ( 8649545 )
1996
31
Vertebrospinal angiography in the evaluation of vertebral and spinal cord disease. ( 8873094 )
1996
32
Spontaneous ejaculation secondary to spinal cord disease. ( 8164008 )
1994
33
Spinal cord disease due to vacuolar myelopathy in AIDS. ( 8039791 )
1994
34
Somatosensory potentials in dogs with naturally acquired thoracolumbar spinal cord disease. ( 8291776 )
1993
35
Repair and regeneration: experimental aspects of spinal cord disease. ( 1515695 )
1992
36
The diagnostic impact of magnetic resonance imaging on the evaluation of suspected spinal cord disease. ( 1441553 )
1992
37
Congenital, hereditary and developmental spinal cord disease. ( 1325226 )
1992
38
Management of bowel dysfunction in children with spinal cord disease or injury by means of the enema continence catheter. ( 1735813 )
1992
39
Disturbed sexual function in patients with spinal cord disease. ( 1921957 )
1991
40
Rehabilitation of patients with spinal cord disease. ( 1921954 )
1991
41
Medical complications of spinal cord disease. ( 1921958 )
1991
42
Disorders of bladder function in spinal cord disease. ( 1921955 )
1991
43
Spinal cord disease in children with HIV-1 infection: a combined molecular biological and neuropathological study. ( 2234312 )
1990
44
Cerebrospinal fluid immunoreactive substance P and somatostatin in neurological patients with peripheral and spinal cord disease. ( 2468107 )
1988
45
Cervical spine: MR imaging with a partial flip angle, gradient-refocused pulse sequence. Part II. Spinal cord disease. ( 3336723 )
1988
46
Spinal-evoked potentials in dogs with acute compressive thoracolumbar spinal cord disease. ( 3674565 )
1987
47
Medical management of spinal cord disease. ( 3113696 )
1987
48
Magnetic resonance imaging of spinal cord disease of childhood. ( 3737301 )
1986
49
The value of paraxial slices in MR-imaging of spinal cord disease. ( 3762914 )
1986
50
Incidence, presentation, and outcome of spinal cord disease in children with systemic cancer. ( 3748677 )
1986

Variations for Spinal Cord Disease

Expression for Spinal Cord Disease

Search GEO for disease gene expression data for Spinal Cord Disease.

Pathways for Spinal Cord Disease

Pathways related to Spinal Cord Disease according to GeneCards Suite gene sharing:

id Super pathways Score Top Affiliating Genes
1 11 AQP4 GDNF MBP TNF

GO Terms for Spinal Cord Disease

Biological processes related to Spinal Cord Disease according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 central nervous system development GO:0007417 9.13 BTD MBP MOG
2 regulation of immunoglobulin secretion GO:0051023 8.62 CD40LG TNF

Sources for Spinal Cord Disease

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....